Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040232 | SCV000063923 | uncertain significance | not specified | 2012-08-21 | criteria provided, single submitter | clinical testing | The Ala1175Thr variant in TTN has not been previously identified in our laborato ry or in the literature. Computational analyses (biochemical amino acid properti es, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. In addition, this variant is located in the last three bases of the exon, which is part of the 5? splice region. Comput ational tools do not suggest an impact to splicing, though this information is n ot predictive enough to rule out pathogenicity. Additional information is needed to fully assess the clinical significance of the Ala1175Thr variant. |
Labcorp Genetics |
RCV001089291 | SCV000555338 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726416 | SCV000701390 | uncertain significance | not provided | 2017-01-31 | criteria provided, single submitter | clinical testing |